TABLE 3.
Medication Regimen at Screening and Randomization
| Screening | Randomization | |
|---|---|---|
| Antihypertensive Medication, n (%) | ||
| ACEi | 68 (84.0) | 81 (100) |
| Diuretic | 53 (65.4) | 73 (90.1) |
| β-Blocker | 33 (40.7) | 58 (71.6) |
| α-Blocker | 3 (3.7) | 24 (29.6) |
| Central adrenergic agonist | 3 (3.7) | 8 (9.9) |
| Vasodilator | 1 (1.2) | 1 (1.2) |
| ARB | 15 (18.5) | — |
| CCB | 5 (6.2) | — |
| Spironolactone | 1 (1.2) | — |
| No. Concomitant non-ACEi | ||
| Antihypertensive Medications, n (%) | ||
| 0 | 20 (24.7) | 7 (8.6) |
| 1 | 23 (28.4) | 15 (18.5) |
| 2 | 26 (32.1) | 31 (38.3) |
| 3 | 10 (12.4) | 25 (30.9) |
| ≥4 | 2 (2.5) | 3 (3.7) |